$934.5 Million Worldwide AI In Pharma Industry to 2031 – by Technology, Drug Type and Application – ResearchAndMarkets.com – Yahoo Finance

DUBLIN, May 03, 2022–(BUSINESS WIRE)–The "AI In Pharma Global Market Report 2022, By Technology, Drug Type, Application" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global ai in pharma market.
This report focuses on ai in pharma market which is experiencing strong growth. The report gives a guide to the ai in pharma market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
The global AI in pharma market is expected to grow from $934.56 million in 2021 to $1,236.09 million in 2022 at a compound annual growth rate (CAGR) of 32.3%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $3626.24 million in 2026 at a CAGR of 30.9%.
Companies Mentioned
Novartis
IBM Watson
Microsoft Corporation
Merck
GNS Healthcare
Google
AstraZeneca
Atomwise Inc.
Exscientia
Cyclica
NVIDIA Corporation
XtalPi Inc.
BenevolentAI
Cloud Pharmaceuticals Inc.
BERG LLC
Bayer
Pfizer
Recursion Pharmaceuticals Inc.
Bristol-Myers Squibb
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The artificial intelligence (AI) in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by artificial intelligence (AI) companies, which are applying in the pharmaceutical industry. Only goods and services traded between entities or sold to end consumers are included.
The main technology types of artificial intelligence (AI) in pharma are context-aware processing, natural language processing, querying method, deep learning. Natural language processing is a a branch of artificial intelligence (AI), concerned with giving computers the ability to understand text and spoken words in the same way that humans do. The various drugs produced are small molecule and large molecules that are used for diagnosis, clinical trial research, drug discovery, research and development and epidemic prediction.
North America was the largest region in the AI in pharma market in 2021. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in the pharmaceutical market. To bring a new drug to the market takes on an average 10-15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs.
Lack of skilled professionals may hamper the growth of artificial intelligence in the pharma market. In 2019, Indeed.com revealed that AI job postings increased 29.1% over the last year and yet, with no uncertainty due to the AI skills gap, searches for AI-related roles decreased by 14.5% over the same period. The shortage of AI skills is seen as a major barrier to the pace of technology's adoption. In fact, 56% of senior AI professionals thought that a lack of additional, qualified AI workers was the single most important hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. Therefore, the lack of skilled professionals may hamper the growth of AI in the pharma market.
Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization and process automation.
For more information about this report visit https://www.researchandmarkets.com/r/smt05o
View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005940/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Facebook-owner Meta Platforms Inc is opening up access to a large language model for artificial intelligence research, the social media company said on Tuesday. Meta said its model was the first 175-billion-parameter language model to be made available to the broader AI research community. "Large language models" are natural language processing systems which are trained on massive volumes of text, and are capable of answering reading comprehension questions or generating new text.
The oil market is undergoing a serious production problem, warns one analyst. Even as prices retreat temporarily amid COVID lockdowns in China.
Veru (NASDAQ: VERU) has found itself the target of a short-seller, and as a result the biotech company's shares took a more than 12% hit on an otherwise upbeat Monday for the wider stock market. Culper Research, an activist short-seller that in its words "seek[s] to expose companies which have misrepresented their operations, failed to disclose significant risks, misappropriated capital, possess accounting irregularities, or otherwise deceived investors," published a blistering report on its short position in Veru. In a 10-tweet thread digesting the report and posted on Monday, Culper accused Veru of "glaring anomalies" in its phase 3 clinical trial of coronavirus drug sabizabulin.
Healthcare ranks as one of the most pressing concerns for retirees, and with medical expenses rising every year, two out of three Americans worry about high healthcare costs in retirement. Models estimate that a retired couple at age 65 will … Continue reading → The post The IRS Just Boosted How Much You Can Contribute for Retirement appeared first on SmartAsset Blog.
(Bloomberg) — Natural gas prices in the U.S. hit a fresh 13-year high on growing concern that stockpiles of the power-plant fuel will fall short of demand this summer.Most Read from BloombergCiti Trader Made Error Behind Flash Crash in Europe StocksRussia Seeks to Annex Occupied Ukraine as Invasion Goals ShiftUkraine Latest: Kremlin Says Putin and Macron Discussed MariupolBiggest Treasury Buyer Outside U.S. Quietly Selling BillionsAlibaba Recovers After Report on ‘Ma’ Briefly Erased $26 Billion
Crude prices are holding well above $100 per barrel, walking a tightrope between bearish covid news from China and a looming EU ban on Russian crude oil imports
Like Pfizer (PFE) and Moderna (MRNA), Novavax (NVAX) has Covid-19 vaccine. Unlike Pfizer or Moderna, Novavax's Covid-19 vaccine hasn't yet been approved by the U.S. Food and Drug Administration (FDA) — not even for restricted "Emergency Use Authorization," or EUA. But it soon might. On Friday last week, the FDA announced that on June 7 it will convene an advisory committee to review Novavax's application for its NVX-CoV2373 vaccine for potential EUA. A positive outcome isn't certain, and even i
The Cupertino tech titan said in a lawsuit filed on Friday that the startup got access to its secrets through a "coordinated campaign" in which the startup hired more than 40 of Apple's former employees.
From our laptops and video game consoles to medical devices and even our cars, chips power much of what we use regularly, from the ways we work and travel to the ways we enjoy leisure time. The global chip shortage picked up steam in the first year of the pandemic and snowballed when China's Semiconductor Manufacturing International Corporation (SMIC) was hit with restrictions from the U.S. Department of Commerce during conflict between China and the U.S. Since then, people have either joined long waiting lists in hopes of eventually buying the items they want, or turned to the secondhand market to buy new cars and electronics, many of them marked up far above their market value.
Want to learn how to retire with $5 million? Here are a few things you can do to stretch your nest egg over the course of your retirement.
BRUSSELS (Reuters) -The European Union will slap new sanctions on Russia for waging war against Ukraine, targeting Moscow's oil industry, more Russian banks and those responsible for disinformation, the EU's top diplomat said on Tuesday. "We are working on the sixth package of sanctions which aims to de-SWIFT more banks, list disinformation actors and tackle oil imports," Josep Borrell, head of the foreign policy unit at the EU's executive European Commission, said in a tweet.
(Bloomberg) — U.S. shale giants stung by billions of dollars in hedging losses are spending big bucks to ditch their positions in a risky bet that prices stay high.Most Read from BloombergCiti Trader Made Error Behind Flash Crash in Europe StocksBiggest Treasury Buyer Outside U.S. Quietly Selling BillionsAlibaba Recovers After Report on ‘Ma’ Briefly Erased $26 BillionUkraine Latest: Johnson to Evoke Wartime History in SpeechEnd of Easy Money Brings a $410 Billion Global Financial ShockCompanies
A waitress is sparking a widespread discussion after her biggest on-the-job pet peeves.
In this article, we will discuss the 15 most valuable e-commerce companies in the world. You can skip our detailed analysis of these companies, and go directly to 5 Most Valuable E-Commerce Companies in the World. Ecommerce has been growing persistently for the past few years. It took over 19 percent share of global retail […]
(Reuters) -Oil prices rose at the start of Asian trade on Wednesday after industry data showed drawdowns in U.S. crude and fuel stockpiles, raising supply concerns and offsetting worries about slowing demand from top importer China. West Texas Intermediate crude futures rose 97 cents, or 1%, to $103.38 a barrel. The gains come on the back of news from Tuesday that the European Union is working on new sanctions against Russia for waging war on Ukraine that will target Moscow's oil industry.
On Monday, the White House announced $3.1 billion is on the way to help with the battery shortage in America.
Washington’s ban on Russian oil imports has left a huge hole in the market, and Brazil is looking to ramp up its output in order to help ease the squeeze
The steep price discounts are a bid by Walmart+, Costco, BJ's, and Sam's Club to lure more customers in the door.
Alphabet Inc's Google will provide any U.S. business over $100,000 worth of online courses in data analytics, design and other tech skills for their workers free of charge, the search company said on Monday. The offer marks a big expansion of Google's Career Certificates, a program the company launched in 2018 to help people globally boost their resumes by learning new tools at their own pace. Over 70,000 people in the United States and 205,000 globally have earned at least one certificate, and 75% receive a benefit such as a new job or higher pay within six months, according to Google.
(Reuters) -Advanced Micro Devices Inc on Tuesday forecast stronger- than-expected full year and second-quarter revenue, with the data center boom boosting demand for its chips, and its shares rose in after-hours trade. The company said it expects revenue of about $6.5 billion, plus or minus $200 million for the current quarter.

source
Connect with Chris Hood, a digital strategist that can help you with AI.

Leave a Reply

Your email address will not be published.

© 2022 AI Caosuo - Proudly powered by theme Octo